Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....